Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura

Journal of Clinical Apheresis

Volumn 16, Issue 3, 2001, Pages 134-138

  Reutter, Jason C ^a,b   Sanders, Kendace F ^a,b   Brecher, Mark E ^a   Jones, Helen G ^a,b   Bandarenko, Nicholas ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Adverse reactions; Allergy; Apheresis; Cryo poor plasma; Plasma exchange; Solvent detergent plasma

Indexed keywords

ANTIHISTAMINIC AGENT; FRESH FROZEN PLASMA;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; HUMAN; HYPOTENSION; INCIDENCE; PLASMA TRANSFUSION; PLASMAPHERESIS; RESPIRATORY DISTRESS; SUPERNATANT; THROMBOTIC THROMBOCYTOPENIC PURPURA; URTICARIA; BLOOD STORAGE; COMPARATIVE STUDY; CRYOPRESERVATION; HYPERSENSITIVITY; METHODOLOGY; PLASMA; RETROSPECTIVE STUDY; STANDARD;

BLOOD PRESERVATION; COMPARATIVE STUDY; CRYOPRESERVATION; HUMAN; HYPERSENSITIVITY; INCIDENCE; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES;

EID: 0034774071     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.1025     Document Type: Article

References (26)

1. Thrombotic thrombocytopenia purpura: Report of 16 cases and review of the literature
2. Therapy of thrombotic thrombocytopenic purpura: An overview
3. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
4. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Clinical experience in 108 patients
5. Members of the United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange
6. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
7. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
8. Involvement of large plasma von Willebrand factor multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation
9. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenia purpura
10. Members of the Canadian Apheresis Study Group: Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura
11. Refractory thrombotic thrombocytopenic purpura: Successful treatment by plasma pheresis with plasma cryosupernatant
12. Effectiveness of the cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura
13. Therapeutic plasma exchange: Complications and management
14. Complications of plasma exchange
15. Frequency of immediate adverse effects associated with therapeutic apheresis
16. Choice of human preparations for transfusion
17. Efficacy of SD-treated plasma during liver transplantation
18. Current Status of solvent/detergent-treated frozen plasma
19. SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available
20. Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura
21. Treatment of TTP using solvent detergent plasma
22. Therapeutic plasma exchange
23. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
24. Plasma anaphylaxis and immediate type reactions